Tor Shwayder
Pediatric Dermatology · Detroit, MINPI 1700964830
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $81,805 of the $99,301 with a category attached, or 82.4%. 13 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 49.4% of the total. 2025 is the largest year on record at $26,058, 4.2 times the $6,159 reported in 2019.
Across 149 payments — averaging $666.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$49K
- Sanofi$31K
- Endo Pharmaceuticals Inc.$9K
- Krystal Biotech Inc$7K
- Amryt Pharma Holdings Ltd$1K
- Chiesi USA, Inc.$498
- plus $959 from 7 others
What the payments were for
- Consulting fees$11,33811%
- Speaking & faculty fees$81,80582%
- Travel & lodging$8841%
- Food & beverage$5,2685%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 47 | $49,025 |
| Sanofi | 60 | $31,485 |
| Endo Pharmaceuticals Inc. | 5 | $8,562 |
| Krystal Biotech Inc | 17 | $7,471 |
| Amryt Pharma Holdings Ltd | 1 | $1,300 |
| Chiesi USA, Inc. | 2 | $498 |
| Regeneron | 5 | $457 |
| Pierre Fabre Pharmaceuticals, Inc. | 6 | $310 |
| Pfizer | 1 | $92 |
| Organon | 1 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Dermavant Sciences, Inc. | 1 | $21 |
| LEO Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric dermatology providers in Michiganto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyjuvekBeremagene Geperpavec-Svdt | 34 | $823,784 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Krystal Biotech IncVyjuvek | $7,471 | $823,78434 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pediatric dermatology providers in Michiganon file to place this against a meaningful peer group, so we don't.
Other pediatric dermatology in Detroit
- Marla JahnkeDetroit$1K
- Allison ZarboDetroit$527
- Bayan MatarnehDetroit$92
- Rachel LaarmanRockford$6K
- Katherine FosterGrand Rapids$1K
- Jennifer MancusoAnn Arbor$405
- Amanda Shepard HayesGrand Rapids$49
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.